J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferry, J.
Right arrow Articles by Colburn, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferry, J.
Right arrow Articles by Colburn, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Articles

Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses

JJ Ferry, AM Horvath, I Bekersky, EC Heath, CF Ryan, and WA Colburn

A randomized, four-way cross-over study was conducted in eight healthy male volunteers to determine the relative and absolute bioavailability of prednisone (PN) and prednisolone (PL). PN and PL were administered as single, oral 10-mg tablet doses and as 10-mg zero-order 0.5-hour intravenous infusions. Comparable mean PN and PL maximum plasma concentrations (Cmax), times for Cmax, areas under the plasma concentration-time curves (AUC), and apparent elimination rate constants between tablet treatments demonstrated that PN and PL tablets were bioequivalent. Absolute bioavailability (F) determinations based on plasma PL concentrations were independent of which IV treatment was used as reference and indicated complete systemic availability of PL from both PN and PL tablets. However, F based on plasma PN data was contradictory. Using IV PN as reference, approximately 70% systemic availability was observed from both tablets, whereas using IV PL as reference, systemic availability was greater than unity. PN and PL are model compounds that exemplify the difficulties involved in accurately determining the relative and absolute bioavailability of substances that undergo reversible metabolism.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
R. Courtney, P. M. Stewart, M. Toh, M.-N. Ndongo, R. A. Calle, and B. Hirshberg
Modulation of 11{beta}-Hydroxysteroid Dehydrogenase (11{beta}HSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11{beta}HSD1 Inhibitor
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 550 - 556.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
N. J. Korman, M. R. Ardern-Jones, V. A. Venning, F. Wojnarowska, J.-C. Bystryn, B. D. Wainwright, J. L. Shupack, G. T. Spigel, P. Joly, J.-C. Roujeau, et al.
Oral and Topical Corticosteroids in Bullous Pemphigoid
N. Engl. J. Med., July 11, 2002; 347(2): 143 - 145.
[Full Text] [PDF]

Home page
 Arch DermatolHome page
N. P. Khumalo, D. F. Murrell, F. Wojnarowska, and G. Kirtschig
A Systematic Review of Treatments for Bullous Pemphigoid
Arch Dermatol, March 1, 2002; 138(3): 385 - 389.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. M. Metz, D. Sabuda, R. J. Hilsden, R. Enns, and J. B. Meddings
Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis
Neurology, December 1, 1999; 53(9): 2093 - 2093.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
F. Carrie, P. Roblot, S. Bouquet, A. Delon, F. Roblot, and B. Becq-Giraudon
Rifampin-Induced Nonresponsiveness of Giant Cell Arteritis to Prednisone Treatment
Arch Intern Med, July 11, 1994; 154(13): 1521 - 1524.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Clinical Pharmacology